ZAZZI MAURIZIO | Elenco docenti

Clemente, T., Torkjazi, G., Capra, N., Gagliardini, R., Cattelan, A.M., Lolatto, R., et al. (2026). Durability of lenacapavir in viremic heavily treatment-experienced people with HIV: real-world data from the PRESTIGIO Registry. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 81(1) [10.1093/jac/dkaf415]. - dettaglio
Martina, M.G., Vagaggini, C., Dreassi, E., De Angelis, M., Nencioni, L., Dragoni, F., et al. (2025). Harnessing prebiotic formamide chemistry: a novel platform for antiviral exploration. SCIENTIFIC REPORTS, 15(1) [10.1038/s41598-025-14001-3]. - dettaglio
Ripamonti, D., Comi, L., Francavilla, A., Valenti, D., Cossu, M.V., Moschese, D., et al. (2025). Long-term durability of dolutegravir plus darunavir/cobicistat dual regimen in highly antiretroviral-experienced people with HIV (DoDaco study). JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 80(6), 1665-1672 [10.1093/jac/dkaf119]. - dettaglio
Clemente, T., Diotallevi, S., Minisci, D., Di Biagio, A., Lolatto, R., Attala, L., et al. (2025). Two-fold increased risk of cardiovascular events in people with MDR HIV: a matched cohort analysis with data from the PRESTIGIO registry. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY [10.1093/jac/dkae465]. - dettaglio
Armenia, D., Marchegiani, G., Spagnuolo, V., Bellocchi, M.C., Galli, L., Clemente, T., et al. (2025). Evaluation of HIV-1 DNA resistance evolution in highly treatment-experienced and multi-resistant individuals under suppressive antiretroviral therapy: a longitudinal study from the PRESTIGIO Registry. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 80(11), 3101-3106 [10.1093/jac/dkaf349]. - dettaglio

Tutte le pubblicazioni